E. Gamelin

发表

Local and sustained delivery of 5‐fluorouracil from biodegradable microspheres for the radiosensitization of glioblastoma

J. Benoit, P. Menei, Marie-Claire Venier, 1999, Cancer.

[Optimizing good use and costs of anticancer drugs: A French inter regional study of the Observatory of Cancer].

J. Douillard, J. Metges, E. Gamelin, 2013, Bulletin du cancer.

Randomized adjuvant study comparing two schemes of 5-fluorouracil and leucovorin in stage B2 and C colon adenocarcinoma: study design and preliminary safety results. Groupe d'Etude et de Recherche Clinique en Oncologie Radiotherapies.

M. Buyse, O. Bouché, P. Piedbois, 2001, Seminars in oncology.

Gemcitabine combined with oxaliplatin in advanced pancreatic adenocarcinoma: final results of a GERCOR multicenter phase II study.

P. Hammel, A. de Gramont, C. Bouleuc, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Clinical pharmacokinetics of oxaliplatin: a critical review.

E. Gamelin, M. Graham, M. Bayssas, 2000, Clinical cancer research : an official journal of the American Association for Cancer Research.

Phase 1/2a study of EKB-569, an irreversible inhibitor of epidermal growth factor receptor, in combination with 5-fluorouracil, leucovorin, and oxaliplatin (FOLFOX-4) in patients with advanced colorectal cancer (CRC).

E. Van Cutsem, S. Tejpar, P. Soulié, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Experimental assessment of tumor growth and dissemination of a microscopic peritoneal carcinomatosis after CO2 peritoneal insufflation or laparotomy

M. Boisdron-Celle, É. Fondrinier, G. Lorimier, 2001, Surgical Endoscopy.

Characterization of a new generation of silicon detector: The SIRIUS side “Strippy-Pad” detector

B. Gall, K. Hauschild, P. Brionnet, 2021 .

Phase III study comparing a semimonthly with a monthly regimen of fluorouracil and leucovorin as adjuvant treatment for stage II and III colon cancer patients: final results of GERCOR C96.1.

M. Buyse, O. Bouché, A. de Gramont, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Semimonthly versus monthly regimen of fluorouracil and leucovorin administered for 24 or 36 weeks as adjuvant therapy in stage II and III colon cancer: results of a randomized trial.

Marc Buyse, Pascal Piedbois, Thierry Andre, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Inflammatory breast metastasis from primary ovarian cancer: case report.

É. Fondrinier, E. Gamelin, V. Verriele, 1999, European journal of gynaecological oncology.

Influence of 5-Fluorouracil-Loaded Microsphere Formulation on Efficient Rat Glioma Radiosensitization

J. Benoit, L. Lemaire, V. Roullin, 2004, Pharmaceutical Research.

Phase Ib/II, open label, multicenter study of intratumoral SD-101 in combination with pembrolizumab in anti-PD-1 treatment naïve patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC).

E. Cohen, A. Algazi, D. Laux, 2018, Annals of Oncology.

Gemcitabine combined with oxaliplatin in advanced pancreatic adenocarcinoma: final results of a GERCOR multicenter phase II study.

C. Bouleuc, A. Gramont, C. Louvet, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.